Abstract
Several different protocols for retrieval of the sentinel node (SN) have been described: gamma probe (GP) and/or dye guided biopsy, preceded by lymphoscintigraphy or not. Especially in American studies, predominantly executed by surgeons, dye or GP guidance only is used with good results. The disadvantages of applying dye only are: an extensive learning curve, lower retrieval rate of the SN and, especially in the learning phase, a higher rate of false negative biopsies. If only GP guidance is applied, the technique seems more simple to master. A recent multicentre study, however, revealed an unacceptably high false negative rate. It must be considered that most published studies were executed by highly experienced surgeons. In most European studies, scintigraphy is a standard part of the procedure. Lymphoscintigraphy provides the surgeon with a “road map”, revealing the number and approximate location of the SNs in the lymphatic basin(s). Scintigraphy proves useful especially if an SN is situated close to the injection site (breast cancer), or if SNs are situated at unexpected locations (head-and-neck or trunk melanoma). A combination of all three available steps results in the highest number of successful procedures with the lowest false negative rate. This may prove to be especially important for general hospitals where the number of biopsy procedures is often smaller compared to specialized centres.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392–399
Krag DN, Meijer S, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:654–658
Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345–2350
Rodier JF, Janser JC. Surgical technical details improving sentinel node identification in breast cancer. Oncol Reports 1997;4:281–283
Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336–340
Krag DN, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. N Engl J Med 1998;339:941–946
Crossin JA, Johnson AC, Stewart PB, et al. Gamma probe guided resection of the sentinel lymph node in breast cancer. Am Surg 1998;64:666–668
Reuhl T, Kaisers H, Markwardt J, et al. Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by sentinel node detection? Dtsch Med Wochenschr 1998;123:583–587
Nieweg DE, Kapteijn BAE, Thompson JF, et al. Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy (review editorial). Eur J Surg Oncol 1997;23:397–398
Balch CM, Murad TM, Soong S, et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979;43:883–888
Balch CM. Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol 1980;3:511–524
Balch CM, Soong S, Bartolucci AA, et al. Efficacy of an ELND of 1 to 4 mmthick melanomas for patients 60 years of age and younger. Ann Surg 1996;3:255–266
Uren RF, Howman-Giles R, Shaw HM, et al. Lymphoscintigraphy in high risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993;34:1435–1440
Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995;22:1238–1241
O’Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170:461–466
Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: Dynamic lymphoscintigraphy followed by Intraoperative gamma probe and vital dye guidance. World J Surg 1997;31:788–793
Krag DN, Meijer S, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654–658
Ross MI. Lymphatic mapping and sentinel node biopsy for early stage melanoma: how we do it at the M.D. Andersen Cancer Center. J Surg Oncol 1997;66:273–276
Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Cancer 1994;73:664–667
Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394–401
Borgstein PJ, Pijpers R, Comans EFI, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coli Surg 1998;186:275–283
Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with Tc-99m colloidal albumin in breast cancer. J Nucl Med 1997;38:366–368
Reintgen D, Cox C, Haddad, et al. The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer. J Nucl Med 1998 (December);12:22N–36N
Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864–1867
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818–1822
Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401
Borgstein PI, Meijer S, Pijpers R. Intradermal blue dye to identify the sentinel lymph node in breast cancer. Lancet 1997;349:1668–1669
Paganelli G, De Cicco C, Cremonesi M, et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998;42:49–53
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pijpers, R., Borgstein, P.J., Teule, G.J.J., Meijer, S. (2000). Vital Dye and Radiolabelled Colloids — Complement or Alternative. In: Schlag, P.M., Veronesi, U. (eds) Lymphatic Metastasis and Sentinel Lymphonodectomy. Recent Results in Cancer Research, vol 157. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57151-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-57151-0_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63070-5
Online ISBN: 978-3-642-57151-0
eBook Packages: Springer Book Archive